Summary
Deficient arylsulfatase-A activity is diagnostic of a neurodegenerative human lysosomal storage disease, metachromatic leukodystrophy. Paradoxically, similar enzyme deficiency also occurs in normal individuals, who are known as being pseudo arylsulfatase-A deficient. We showed previously that this phenotype is associated with a structural gene mutation that produces an exceptionally labile enzyme. We now report on the nature and consequence of this mutation. When the mutant arylsulfatase-A is deglycosylated by endoglycosidase H, only one smaller molecular species was generated, instead of the two from the normal enzyme. This is consistent with the loss of one of the two N-linked oligosaccharide side chains known to be present on the wild-type enzyme. Quantitative analysis of mannose and leucine incorporation showed that the mutant enzyme incorporated two- to tenfold less mannose than the normal enzyme on a molar basis. This deficient glycosylation was specific to arylsulfatase-A. Another lysosomal enzyme not affected in this mutation, beta-hexosaminidase, was glycosylated normally in the mutant cells. The remaining single oligosaccharide side chain released from the mutant arylsulfatase-A by pronase digestion was normally processed to complex and high-mannose forms. However, the high-mannose side chains contained 30% fewer phosphorylated residues than those of the normal enzyme. Nevertheless, this reduced level of phosphorylation did not prevent targeting of the mutant enzyme to the lysosomes, a process normally mediated through phosphorylated mannose residues. In conclusion, pseudo arylsulfatase-A deficiency is a unique human mutation associated with reduced glycosylation and phosphorylation of a lysosomal enzyme with the loss of one of the two carbohydrate side chains. The mutation results in greatly reduced enzyme stability, thus indicating a role for oligosaccharides in maintaining enzyme stability within the degradative environment of the lysosomes. However, the residual catalytic activity or subcellular targeting of the mutant enzyme was not affected. These properties probably account for the benign clinical presentation of pseudo arylsulfatase-A deficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- PD:
-
Pseudo arylsulfatase-A Deficiency
- ARA:
-
Arylsulfatase-A
References
Kornfeld S: Trafficking of lysosomal enzymes in normal and disease states. J Clin Invest 77: 1–6, 1985
Navon R, Padeh B, Adam A: Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet 25: 287–93, 1973
Vidgoff J, Buist NRM, O'Brien JS: Absence of beta-Nacetyl-D-hexosaminidase A activity in a healthy woman. Am J Hum Genet 25: 372–81, 1973
Dreyfus JC, Poenaru L, Svennerholm L: Absence of hexosaminidase A and B in a normal adult. N Engl J Med 292: 61–3, 1975
Wenger DA, Riccardi WM: Possible misdiagnosis of Krabbe disease. J Pediatr 88: 76–9, 1976
Ramage P, Cunningham WL: The occurrence of low alpha-L-fucosidase activities in normal human serum. Biochim-Biophys Acta 403: 473–6, 1975
Dubois G, Turpin JC, Baumann N: Absence of ASA activity in healthy father of a patient with metachromatic leukodystrophy. N Engl J Med 293: 302, 1975
Kihara H: Genetic heterogeneity in metachromatic leukodystrophy. Am J Hum Genet 34: 171–81, 1982
Chang PL, Davidson RG: Pseudo arylsulfatase-A deficiency in healthy individuals: Genetic and biochemical relationship to metachromatic leukodystrophy. Proc Natl Acad Sci USA 80: 7323–7, 1983
Bach G, Neufeld EF: Synthesis and maturation of cross-reactive glycoprotein in fibroblasts deficient in arylsulfatase A activity. Biochem Biophys Res Commun 112: 198–205, 1983
Herz B, Bach G: Arylsulfatase A in pseudo-deficiency. Hum Genet 66: 147–50, 1984
Ameen M, Chang PL: Pseudo arylsulfatase A deficiency: Biosynthesis of an abnormal arylsulfatase A FEBS LETT 219: 130–4, 1987
Fluharty AL, Meek WE, Kihara H: Pseudo arylsulfatase A deficiency: evidence for a structurally altered enzyme. Biochem Biophys Res Commun 112: 191–7, 1983
Austin JH, Balasubramanian AS, Pattabiraman TN, Saraswathi S, Basu DK, Bachhawat BK: A controlled study of enzymic activities in three human disorders of glycolipid metabolism. J Neurochem 10: 805–16, 1963
Porter MT, Fluharty AL, Kihara H: Metachromatic leukodystrophy: arylsulfatase-A deficiency in skin fibroblast cultures. Proc Natl Acad Sci USA 62: 887–91, 1969
Mehl E, Jatzkowitz H: Evidence for the genetic block in metachromatic leukodystrophy (ML). Biochem Biophys Res Commun 19: 407–11, 1965
Butterworth J, Broadhead DM, Keay AJ: Low arylsulphatase A activity in a family without metachromatic leukodystrophy. Clin Genet 14: 13–8, 1978
Dubois G, Harzer K, Baumann N: Very low arylsulfatase A and cerebroside sulfatase activities in leukocytes of healthy members of metachromatic leukodystrophy family. Am J Hum Genet 29: 191–4, 1977
Lott IT, Dulaney JT, Milunsky A, Hoefnagel D, Moser HW: Apparent biochemical homozygosity in two obligatory heterozygotes for metachromatic leukodystrophy. J Pediatr 89: 438–40, 1976
Kihara H, Fluharty AL, Tsay KK, Bachman RP, Stephens JD, Ng WG: Prenatal Diagnosis of pseudo arylsulphatase A deficiency. Prenat Diagn 3: 29–34, 1983
Schaap T, Zlotogora J, Elian E, Barak Y, Bach G: The genetics of the aryl sulfatase A locus. Am J Hum Genet 33: 531–9, 1981
Chang PL, Joubert GI, Davidson RG: Non-selective isolation of human somatic cell hybrids by unit-gravity sedimentation. Nature 278: 168–70, 1979
Chang PL, Rosa NE, Varey PA, Kihara H, Kolodny EH, Davidson RG: Diagnosis of pseudo-arylsulfatase A deficiency with electrophoretic techniques. Pediatr Res 18: 1042–5, 1984
Shapira E, Nadler HL: The nature of the residual arylsulfatase activity in metachromatic leukodystrophy. J Pediatr 86: 881–4, 1975
Porter MT, Fluharty AL, Harris SE, Kihara H: The accumulation of cerebroside sulfates by fibroblasts in culture from patients with late infantile metachromatic leukodystrophy. Arch Biochem Biophys 138: 646–52, 1970
Waheed A, Hasilik A, von Figura K: Synthesis and processing of arylsulfatase A in human skin fibroblasts. Hoppe-Seyler's Z. Physiol Chem 363: 425–30, 1982
Hreidarsson SJ, Thomas GH, Kihara H, Fluharty AL,Kolodny EH, Moser HW, Reynolds LW: Impaired cerebroside sulfate hydrolysis in fibroblasts of sibs with ‘pseudo’ arylsulfatase A deficiency without metachromatic leukodystrophy. Pediatr Res 17: 701–4, 1983
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–5, 1970
Cummings RD, Kornfeld S: Fractionation of asparagine-linked oligosaccharides by serial lectin-agarose affinity chromatography. J Biol Chem 257: 11235–40, 1982
Varki A, Kornfeld S: The spectrum of anionic oligosaccharides released by endo-β-N-acetylglucosaminidase H from glycoprotein. J Biol Chem 258: 2808–18, 1983
Chang PL, Ameen M, Yu CA, Kelly BM: Effect of ammonium chloride on subcellular distribution of lysosomal enzymes in human fibroblasts. Exp Cell Res 176: 258–67, 1988
Baum H, Dodgson KS, Spencer B: The assay of arylsulphatases A and B in human urine. Clin Chim Acta 4: 453–5, 1959
Chang PL, Rosa NE, Davidson RG: Differential assay of arylsulfatase A and B activities: a sensitive method for cultured human cells. Anal Biochem 117: 382–9, 1981
Holandar VP: Acid phosphatase. In The Enzymes (Boyer PD, ed) New York, 1971, Vol IV, p 450
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–4, 1976
Hasilik A, Neufeld EF: Biosynthesis of lysosomal enzymes in fibroblasts. J Biol Chem 255: 4937–45, 1980
Gabel CA, Goldberg DE, Kornfeld S: Lysosomal enzyme oligosaccharide phosphorylation in mouse lymphoma cells: specificity and kinetics of binding to the mannose 6-phosphate receptor in vivo. J Cell Biol 95: 536–42, 1982
Foster SA, Gabel CA: Mannose 6-phosphate receptor-mediated endocytosis of acid hydrolases: internalization of beta-glucuronidase is accompanied by a limited dephosphorylation. J Cell Biol 103: 1817–27, 1986
Kaplan A, Achord DT, Sly WS: Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc Natl Acad Sci USA 74: 2026–30, 1977
Sando GN, Neufeld EF: Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-L-iduronidase, by cultured human fibroblasts. Cell 12: 619–27, 1977
Ullrich K, Mersmann G, Weber E, von Figura K: Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem J 170: 643–50, 1978
Waheed A, Hasilik A, von Figura K: Enhanced breakdown of arylsulfatase A in multiple sulfatase deficiency. Eur J Biochem 123: 317–21, 1982
Waheed A, Steckel F, Hasilik A, von Figura K: Two allelic forms of human arylsulfatase A with different numbers of asparagine-linked oligosaccharides. Am J Hum Genet 35: 228–33, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ameen, M., Lazzarino, D.A., Kelly, B.M. et al. Deficient glycosylation of arylsulfatase A in pseudo arylsulfatase-A deficiency. Mol Cell Biochem 92, 117–127 (1990). https://doi.org/10.1007/BF00218129
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00218129